What Should You Eat—and Avoid—While Taking Trastuzumab for Stomach Cancer?
You're on a targeted therapy like trastuzumab (Herceptin), aiming precisely at the cancer's weak spots. But could your diet be helping or hindering its work? The foods you eat contain powerful compounds that interact with the same cellular pathways your drug targets. Getting this right can make a real difference.
Key Findings
- Oregano and lemon peel contain compounds (galangin and chrysin) that inhibit the PI3K/AKT and MAPK signaling pathways [3, 4, 6]—key growth signals that stomach cancer cells often use to survive.
- Blackberries and salmon contain compounds (ellagic acid and folic acid) that activate the PI3K-Akt and mTOR signaling pathways [11, 14]—this could potentially encourage cancer cell growth and is a reason for caution.
- Papaya is a source of lycopene, which has a complex, dual effect on the MAPK pathway, both activating and inhibiting it in different contexts [1, 2]. Its net effect in stomach cancer is unclear.
Molecular Pathway
Why Nutrition Matters in Stomach Cancer
Trastuzumab works by targeting the HER2 protein, a major driver of growth in some stomach cancers. But cancer cells are cunning; they often use backup pathways to continue growing even when HER2 is blocked. Two of the most common backup plans involve the PI3K/AKT and MAPK signaling pathways—these are like secondary growth engines.
Your stomach cancer’s genetic landscape is shaped by frequent mutations in genes like TP53, which normally acts as a "brake" on tumor growth. When this brake fails, cancer cells rely even more heavily on growth signals from pathways like PI3K/AKT and MAPK. The food you eat can directly influence these pathways. Some compounds can help turn these secondary engines off, while others might accidentally turn them on, potentially making your treatment less effective.
Molecular Pathway
Foods and Compounds That May Support Your Treatment
The goal here is to find compounds that help shut down the cancer's alternative growth pathways, particularly PI3K/AKT and MAPK.
Common Oregano: Targeting Growth Pathways
Common oregano is rich in a flavonoid called galangin. Laboratory research on other cancers shows that galangin acts directly on the pathways stomach cancer cells might use to escape treatment. It inhibits PI3K/AKT signaling in cancer [3] and also inhibits the MAPK signaling pathway [4]. By blocking these critical growth signals, galangin may help keep cancer cells in check. Fresh or dried oregano is an easy addition to sauces, soups, and roasted vegetables.
Lemon Peel: Promoting Cancer Cell Death
Don't throw out that lemon peel! It contains chrysin, a compound that has shown intriguing mechanisms in lab studies. Chrysin activates ferroptosis [5]—a specific type of iron-dependent cell death that scientists are keen to trigger in cancer cells. Furthermore, it inhibits the PI3K-Akt signaling pathway [6], cutting off a major survival signal. Use a microplane to zest organic lemon peel over salads, fish, or into tea.
Pepper (Spice): Limiting Cancer Movement
The compound delphinidin, found in spices like pepper, may help in two ways. It inhibits focal adhesion [7]—these are like molecular anchors that cells use to grip surfaces and move. It also inhibits the MAPK signaling pathway [8]. By disrupting these processes, delphinidin could potentially help prevent cancer from spreading. A sprinkle of black pepper is a versatile way to add it to almost any savory dish.
Molecular Pathway
Foods to Approach with Caution
Some foods contain compounds that activate the very pathways you want to suppress. While these foods can be part of a healthy diet for others, you may want to discuss them with your oncologist.
The PI3K-Akt and mTOR Activation Concern
Two compounds show clear evidence of activating pro-growth pathways that could theoretically interfere with treatment.
- Ellagic acid, found in blackberries, activates the PI3K-Akt signaling pathway [11]. This pathway is a primary growth signal for many cancers.
- Folic acid, found in fish like chum salmon, activates the mTOR signaling pathway [14]. mTOR acts like a central nutrient sensor that tells cells to grow and multiply.
Because trastuzumab aims to shut down growth signals, consuming compounds that actively turn these signals on might be counterproductive.
The Complexity of Conflicting Signals
Some foods present a paradox, making them difficult to recommend.
- Catechin, found in evergreen blackberries, has been shown to both activate and inhibit PI3K-Akt signaling in different studies [15, 16]. Without a clear understanding of its net effect in stomach cancer, it is best to consume it in moderation rather than in supplement form.
- Lycopene from papaya also has dual actions, both activating and inhibiting MAPK signaling [1, 2]. This makes its overall impact uncertain.
How Food Interactions Relate to Trastuzumab
Trastuzumab targets the HER2 receptor to slow down cancer proliferation. Its effectiveness is closely tied to a network of genes that regulate the cell cycle—the process by which a cell divides. Key genes involved include CCNE1, GSK3B, and pathways like p38 MAPK.
The beneficial foods listed above contain compounds that also target proliferation, but from a different angle. By inhibiting pathways like PI3K/AKT and MAPK, they are attacking the same problem—uncontrolled cell growth—that trastuzumab is. This complementary action is why they may be supportive.
Conversely, the foods in the caution section risk doing the opposite. Activating PI3K-Akt or mTOR could send a "grow" signal that might blunt the "stop growing" signal from your drug.
A crucial reminder: This information is based on laboratory and preclinical research. It reveals potential mechanisms of action, but it is not a substitute for medical advice from your oncology team. Always discuss significant dietary changes with your doctor and dietitian, who can provide guidance tailored to your specific treatment plan and nutritional needs.
Want recommendations personalized to your exact diagnosis?
addon scores every food and supplement against your specific cancer type, treatment regimen, and genetic mutations — backed by the same evidence you see in this article.
Get your free preview